Diana Sprij-Mooij

The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5

Leo J. Hofland, Joost van der Hoek, Richard A. Feelders et al. · European Journal of Endocrinology · 2005 · 274 citations · Full text

Life Sciences, Endocrinology, Pharmacology +17

The Novel Somatostatin Analog SOM230 Is a Potent Inhibitor of Hormone Release by Growth Hormone- and Prolactin-Secreting Pituitary Adenomas<i>in Vitro</i>

Leo J. Hofland, Joost van der Hoek, Peter M. van Koetsveld et al. · The Journal of Clinical Endocrinology & Metabolism · 2004 · 180 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Immunoreactivity Score Using an Anti-sst2A Receptor Monoclonal Antibody Strongly Predicts the Biochemical Response to Adjuvant Treatment with Somatostatin Analogs in Acromegaly

Federico Gatto, Richard A. Feelders, Rob van der Pas et al. · The Journal of Clinical Endocrinology & Metabolism · 2012 · 174 citations · Full text

Medicine, Endocrinology, Pathology +14

Distinct functional properties of native somatostatin receptor subtype 5 compared with subtype 2 in the regulation of ACTH release by corticotroph tumor cells

Joost van der Hoek, Marlijn Waaijers, Peter M. van Koetsveld et al. · American Journal of Physiology-Endocrinology and Metabolism · 2005 · 152 citations · Full text

Life Sciences, Biochemistry, Endocrinology +17

The role of mTOR inhibitors in the inhibition of growth and cortisol secretion in human adrenocortical carcinoma cells

Maria Cristina De Martino, Peter M. van Koetsveld, Richard A. Feelders et al. · Endocrine Related Cancer · 2012 · 47 citations · Full text

Medicine, Oncology, Pharmacology +17